Concurrent Mutations in

PHF6 SF3B1 myeloid neoplasms

Journal

Biology
ISSN: 2079-7737
Titre abrégé: Biology (Basel)
Pays: Switzerland
ID NLM: 101587988

Informations de publication

Date de publication:
21 Dec 2022
Historique:
received: 17 11 2022
revised: 16 12 2022
accepted: 17 12 2022
entrez: 21 1 2023
pubmed: 22 1 2023
medline: 22 1 2023
Statut: epublish

Résumé

It has been reported that gene mutations in

Identifiants

pubmed: 36671709
pii: biology12010013
doi: 10.3390/biology12010013
pmc: PMC9855138
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

N Engl J Med. 2011 Oct 13;365(15):1384-95
pubmed: 21995386
N Engl J Med. 2012 Mar 22;366(12):1079-89
pubmed: 22417203
Hum Pathol. 2019 Apr;86:1-11
pubmed: 30594750
J Mol Diagn. 2019 Jan;21(1):89-98
pubmed: 30577887
Stem Cells Int. 2017;2017:6962379
pubmed: 28197208
J Mol Diagn. 2018 Nov;20(6):717-737
pubmed: 30138727
Leukemia. 2012 May;26(5):1135-7
pubmed: 22064353
Leukemia. 2014 Feb;28(2):241-7
pubmed: 24220272
Blood. 2013 Nov 21;122(22):3616-27; quiz 3699
pubmed: 24030381
Front Oncol. 2021 Jul 26;11:704471
pubmed: 34381727
Blood. 2020 Oct 15;136(16):1851-1862
pubmed: 32573691
Blood Adv. 2020 Apr 14;4(7):1192-1196
pubmed: 32211880
Blood. 2020 Jul 9;136(2):157-170
pubmed: 32347921
Am J Clin Pathol. 2021 Sep 8;156(4):679-690
pubmed: 33978189
Neoplasia. 2021 Nov;23(11):1101-1109
pubmed: 34601234
N Engl J Med. 2016 Jun 9;374(23):2209-2221
pubmed: 27276561
Blood. 2011 Dec 22;118(26):6904-8
pubmed: 22039264
Leukemia. 2016 Nov;30(11):2270-2273
pubmed: 27479181
J Hematol Oncol. 2014 Oct 04;7:74
pubmed: 25281355

Auteurs

Zhuang Zuo (Z)

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

L Jeffrey Medeiros (LJ)

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Sofia Garces (S)

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Mark J Routbort (MJ)

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Chi Young Ok (CY)

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Sanam Loghavi (S)

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Rashmi Kanagal-Shamanna (R)

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Fatima Zahra Jelloul (FZ)

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Guillermo Garcia-Manero (G)

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Kelly S Chien (KS)

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Keyur P Patel (KP)

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Rajyalakshmi Luthra (R)

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

C Cameron Yin (CC)

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Classifications MeSH